YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Amicus, Biogen Sign Deal for Parkinson's Disease


September 10, 2013 | Amicus Therapeutics and Biogen Idec announced a deal today to discover, develop and commercialize small molecule drugs for Parkinson's Disease. The expenses associated with the endeavor will be borne solely by Biogen. Xconomy
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.